Hospira Recalls Propofol Injectable Emulsion, USP

Lake Forest, Ill.-based Hospira has voluntarily recalled seven lots of its Propofol Injectable Emulsion, USP, citing metal particulate embedded in the interior neck of the vial as well as free-floating metal particulates found in the vials.

Hospira has not received any reports of adverse events associated with these lots. However, if injected, the particulate matter could lead to local inflammation or obstructed capillaries.

More Articles on Recalls:

What the Increase in Device Recalls Means for Hospitals
Covidien Recalls Pipeline Embolization Device, Alligator Retrieval Device
Dräger Recalls Ventilator Power Supply Unit for Evita, Babylog Ventilators

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.